/LITS
LITS Stock - Lite Strategy, Inc.
Healthcare|BiotechnologyNASDAQ
$1.43+5.93%
+$0.08 (+5.93%) • Dec 19
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.57
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for LITS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.42 – $1.44
TARGET (TP)$1.64
STOP LOSS$1.32
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.05
52W High$9.00
52W Low$1.33
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | N/A | $65.30M | $48.82M | $40.70M | $34.80M |
| Gross Profit | $-368,000 | $65.30M | $48.82M | $40.70M | $33.39M |
| Gross Margin | N/A | 100.0% | 100.0% | 100.0% | 96.0% |
| Operating Income | $-17,455,000 | $14.54M | $-36,764,000 | $-75,484,000 | $-60,424,000 |
| Net Income | $-15,945,000 | $17.78M | $-31,838,000 | $-54,454,000 | $-41,314,000 |
| Net Margin | N/A | 27.2% | -65.2% | -133.8% | -118.7% |
| EPS | $-2.39 | $2.67 | $-4.78 | $-8.75 | $-7.34 |
Company Overview
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
LITSBeat Rate
80%
Last 5 quarters
Avg Surprise
+134.6%
EPS vs Estimate
Beats / Misses
4/1
Last 12 quarters
Latest EPS
$-0.12
Q4 2025
EPS Surprise History
Q1 24
-17.5%
$-1.66vs$-1.41
Q2 24
+7.8%
$-1.37vs$-1.49
Q2 24
No data
Q3 24
+29.3%
$-1.20vs$-1.70
Q4 24
+81.7%
$-0.40vs$-2.20
Q2 25
No data
Q2 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 11, 2026 | — | — | — | — |
Q4 2025 | Nov 14, 2025 | — | $-0.12 | — | — |
Q2 2025 | Jun 30, 2025 | — | $-0.40 | — | — |
Q2 2025 | May 13, 2025 | — | $-0.39 | — | — |
Q4 2024 | Dec 31, 2024 | $-2.20 | $-0.40 | +81.7% | ✓ BEAT |
Q3 2024 | Sep 30, 2024 | $-1.70 | $-1.20 | +29.3% | ✓ BEAT |
Q2 2024 | Jun 30, 2024 | — | $-2.76 | — | — |
Q2 2024 | May 9, 2024 | $-1.49 | $-1.37 | +7.8% | ✓ BEAT |
Q1 2024 | Feb 13, 2024 | $-1.41 | $-1.66 | -17.5% | ✗ MISS |
Q4 2023 | Nov 9, 2023 | $-1.79 | $8.46 | +571.3% | ✓ BEAT |
Latest News
Loading news...
Frequently Asked Questions about LITS
What is LITS's current stock price?
Lite Strategy, Inc. (LITS) is currently trading at $1.43 per share. The stock has moved +5.93% today.
What is the analyst price target for LITS?
No analyst price targets are currently available for this stock.
What sector is Lite Strategy, Inc. in?
Lite Strategy, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.
What is LITS's market cap?
Lite Strategy, Inc. has a market capitalization of $0.05 billion, making it a small-cap company.
Does LITS pay dividends?
No, Lite Strategy, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACET
Adicet Bio, Inc.
$0.49
Mkt Cap: $0.0B
ACRV
Acrivon Therapeutics, Inc. Common Stock
$2.16
Mkt Cap: $0.1B
HOWL
Werewolf Therapeutics, Inc.
$0.69
Mkt Cap: $0.0B
IMUX
Immunic, Inc.
$0.57
Mkt Cap: $0.1B
IOBT
IO Biotech, Inc.
$0.66
Mkt Cap: $0.0B
NTRB
Nutriband Inc.
$4.49
Mkt Cap: $0.1B
PMVP
PMV Pharmaceuticals, Inc.
$1.24
Mkt Cap: $0.1B
RLMD
Relmada Therapeutics, Inc.
$4.35
Mkt Cap: $0.3B
TCRX
TScan Therapeutics, Inc.
$0.90
Mkt Cap: $0.1B
XBIT
XBiotech Inc.
$2.50
Mkt Cap: $0.1B
Explore stocks similar to LITS for comparison